Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Flanagan

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|June 27, 2001
25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissueV Tangpricha, J N Flanagan, L W Whitlatch, et al.
Anticancer Research|August 5, 2006
Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin DJohn N Flanagan, Michael V Young, Kelly S Persons, et al.
Anticancer Research|August 5, 2006
Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in normal and malignant breast tissueMichael Friedrich, Dagmar Diesing, Tim Cordes, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 14, 2011
Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cellsDiego Iglesias-Gato, Shasha Zheng, John N Flanagan, et al.
Carcinogenesis|January 20, 2004
The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin DMichael V Young, Gary G Schwartz, Lilin Wang, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 26, 2002
25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transferLyman W Whitlatch, Michael V Young, Gary G Schwartz, et al.
The Journal of Clinical Endocrinology and Metabolism|May 28, 2009
Role of follistatin in promoting adipogenesis in womenJohn N Flanagan, Kristina Linder, Niklas Mejhert, et al.
Anticancer Research|July 25, 2008
Prostate 25-hydroxyvitamin D-1alpha-hydroxylase is up-regulated by suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitorLilin Wang, Kelly S Persons, Dan Jamieson, et al.
American Journal of Human Genetics|March 25, 2000
Evidence for variable selective pressures at MC1RR M Harding, E Healy, A J Ray, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2019
Muscle Strength, Size, and Composition Following 12 Months of Gender-affirming Treatment in Transgender IndividualsAnna Wiik, Tommy R Lundberg, Eric Rullman, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|June 27, 2001
25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissueV Tangpricha, J N Flanagan, L W Whitlatch, et al.
Anticancer Research|August 5, 2006
Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin DJohn N Flanagan, Michael V Young, Kelly S Persons, et al.
Anticancer Research|August 5, 2006
Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in normal and malignant breast tissueMichael Friedrich, Dagmar Diesing, Tim Cordes, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 14, 2011
Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cellsDiego Iglesias-Gato, Shasha Zheng, John N Flanagan, et al.
Carcinogenesis|January 20, 2004
The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin DMichael V Young, Gary G Schwartz, Lilin Wang, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 26, 2002
25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transferLyman W Whitlatch, Michael V Young, Gary G Schwartz, et al.
The Journal of Clinical Endocrinology and Metabolism|May 28, 2009
Role of follistatin in promoting adipogenesis in womenJohn N Flanagan, Kristina Linder, Niklas Mejhert, et al.
Anticancer Research|July 25, 2008
Prostate 25-hydroxyvitamin D-1alpha-hydroxylase is up-regulated by suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitorLilin Wang, Kelly S Persons, Dan Jamieson, et al.
American Journal of Human Genetics|March 25, 2000
Evidence for variable selective pressures at MC1RR M Harding, E Healy, A J Ray, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2019
Muscle Strength, Size, and Composition Following 12 Months of Gender-affirming Treatment in Transgender IndividualsAnna Wiik, Tommy R Lundberg, Eric Rullman, et al.
Pageof 6